Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Sees Significant Decrease in Short Interest

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the recipient of a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 13,175 shares, a drop of 75.1% from the April 30th total of 52,840 shares. Based on an average trading volume of 28,873 shares, the short-interest ratio is currently 0.5 days. Approximately 4.0% of the shares of the stock are sold short.

Defiance Daily Target 2X Long LMND ETF Price Performance

NASDAQ LMNX traded down $0.15 during midday trading on Friday, hitting $13.74. The company had a trading volume of 55,596 shares, compared to its average volume of 45,458. The firm has a 50-day moving average price of $16.21 and a 200-day moving average price of $25.72. The company has a market capitalization of $4.53 million, a PE ratio of 26.94 and a beta of -12.97. The company has a current ratio of 8.37, a quick ratio of 6.08 and a debt-to-equity ratio of 0.52. Defiance Daily Target 2X Long LMND ETF has a twelve month low of $10.81 and a twelve month high of $55.00.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.